Laurent Greillier
About Laurent Greillier
Laurent Greillier is a Professor of Universities and a medical leader in oncology at APHM in Marseille, France. He has extensive experience in pulmonary medicine and oncology, coordinating specialized programs and actively participating in various research and professional organizations since 2017.
Work at Aix-Marseille University
Laurent Greillier has been a Professeur des Universités at Aix-Marseille Université since 2017. He coordinates the Diplôme d'Etudes Spécialisées en Pneumologie, contributing to the education and training of medical professionals in the field of pulmonology. His role emphasizes the integration of academic knowledge with clinical practice, enhancing the quality of medical education at the university.
Current Role at APHM
Since 2022, Laurent Greillier has served as Responsable médical de la Fédération de Cancérologie at Assistance Publique - Hôpitaux de Marseille (APHM). In 2023, he was appointed Chef du Département de Pneumologie, Allergologie et Cancérologie. His responsibilities include overseeing cancer care and treatment protocols, ensuring the delivery of high-quality medical services in the region.
Education and Expertise
Laurent Greillier studied at Aix-Marseille University, where he completed his MD and PhD in Medicine over a span of 21 years, from 1995 to 2016. His extensive education has equipped him with a strong foundation in medical science, particularly in oncology and pulmonology, which informs his clinical and academic work.
Leadership in Oncology Groups
Laurent Greillier holds several leadership positions in oncology-related organizations. He has been the President of the Groupe Français de Pneumo-Cancérologie (GFPC) since June 2022 and serves as Secrétaire Général of the Oncologie group (GOLF) within the Société de Pneumologie de Langue Française since January 2023. These roles involve guiding research and clinical practices in thoracic oncology.
Research Contributions
Laurent Greillier is actively involved in research activities within the COMPO team at the Centre de Recherche en Cancérologie de Marseille. His research focuses on advancements in cancer treatment, particularly in the context of thoracic oncology, contributing to the broader scientific community's understanding of cancer therapies.